Bart Barlogie, M.D., Ph.D.

Bart Barlogie, M.D., Ph.D., professor of medicine and pathology at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, is the director of the UAMS Myeloma Institute for Research and Therapy.

Dr. Barlogie is an internationally recognized authority on the use of novel therapies to combat multiple myeloma for improved patient outcome. On the faculty at UAMS since 1989, Dr. Barlogie has built the largest center in the world devoted exclusively to clinical care for and research in multiple myeloma. More than 9,000 patients from every state in the U.S. and more than 50 countries have come to the Myeloma Institute.

With a keen insight into the biology of myeloma, Dr. Barlogie pioneered the use of tandem peripheral stem cell transplant for multiple myeloma. Other firsts under Dr. Barlogie’s leadership include performing transplants on an outpatient basis, safely transplanting patients age 70 and older, transplanting patients with renal disease, and introducing thalidomide as anti-angiogenesis therapy. Dr. Barlogie’s Total Therapy approach, by which multiple agents are provided upfront, has continually increased median survival, with a projected median survival of 15 years for patients enrolled in the third Total Therapy protocol.

Dr. Barlogie has successfully secured National Cancer Institute funding for his translational research program project, Growth Control of Multiple Myeloma, for 20 consecutive years.

A consummate clinician scientist, Dr. Barlogie has authored more than 544 papers in prestigious journals such as Blood, New England Journal of Medicine, Journal of Clinical Oncology, British Journal of Haematology, and Cancer. He has more than 595 abstracts and 75 book chapters to his credit, and serves on the editorial board of numerous journals.

Dr. Barlogie received his M.D. from the University of Heidelberg and completed his medical training at the Universities of Munich and Muenster. He earned his Ph.D. at the Max Planck Institute for Medical Research. Dr. Barlogie was at M.D. Anderson Cancer Center prior to joining the UAMS faculty.


Make an appointment with the UAMS Myeloma Institute

Professional Certifications and Education

  • Internal Medicine
  • Hematology/Oncology
  • Fellowship: Clinical Fellowship in Oncology, M. D. Anderson Hospital and Tumor Institute
  • University: M.D. DEGREE: Heidelberg University (Germany)
  • Residency: University of Munich (Germany)
  • University: Ph.D. DEGREE: Max-Planck Institute for Medical Research (Germany)
  • Residency: University of Muenster (Germany)
  • Residency: University of Muenster (Germany)


  • Multiple Myeloma
  • Myeloma & Transplantation
  • MGUS
  • Smoldering Myeloma
  • Waldenstrom Macroglobulinemia
  • Amyloidosis
  • POEMS syndrome

Conditions/Diseases Treated

UAMS doctors treat a broad range of conditions some of which may not be listed below.

  • Multiple Myeloma
  • Bone Marrow Transplantation
  • Multiple Myeloma pain
  • MGUS
  • Smoldering Myeloma
  • Waldenstrom Macroglobulinemia
  • Amyloidosis
  • POEMS Syndrome
  • MDS

Languages Spoken

  • English
  • German

Medical Interpreters are available to help patients communicate with hospital and clinic staff. Other services available is translation of patient education materials and hospital forms. For more information, please contact interpreting services at 501-395-8231 or visit us on the web.

Additional Links

Patient Story - Myeloma Patient 'In Good Hands'
Patient Story - Unexpected Chance of Plans

doc photo

Clinic Location

  • Cancer: Myeloma Clinic

Type of Doctor

  • For Adults

Hospital Affiliations

  • University of Arkansas for Medical Sciences

Institute Affiliations

  • Myeloma Institute for Research and Therapy

Academic Appointment

  • Professor of Medicine and Pathology; Tommy May Chair in Oncology
    Department: Myeloma & Transplantation

Recent Video

Contact Us

4301 West Markham Street
Little Rock, Arkansas 72205


 Women's Health